Pharmacists support real-time monitoring across AustraliaBack to previous page
php echo wp_list_categories(); ?>
August 9, 2017
New legislation to deliver a real-time prescription monitoring system in Victoria has been welcomed by the peak national body for pharmacists, the Pharmaceutical Society of Australia (PSA).
Legislation introduced into the Victorian Parliament yesterday will establish the legislative framework for a Victorian real-time monitoring system.
PSA Victorian President Benjamin Marchant said PSA welcomed the long-overdue system, which will support clinical decision-making by prescribers and pharmacists to optimise use of medicines and save lives in Victoria.
“The system will allow timely and relevant information to be shared among prescribers and pharmacists, ensuring potent medicines are used safely,” Mr Marchant said. “The system will identify people at risk of harm and provide referral pathways for pharmacists to support our patients.
“PSA supports the Victorian legislation’s mandatory requirements for prescribers and pharmacists. The system should be integrated and streamlined for prescribing and dispensing software to ensure it is effective and useable.”
PSA National President Dr Shane Jackson said PSA applauded Federal Health Minister Greg Hunt’s announcement at PSA17 on Friday 28 July that the Government would commit $16 million to immediately establish a real-time monitoring system for dangerous prescription drugs.
“In recent years PSA has strongly advocated for a national real-time recording system to monitor specific high-risk medicines,” Dr Jackson said.
“We believe this issue requires urgent collaboration and coordination across all jurisdictions to minimise unintended harm for consumers seeking treatment for pain or managing addiction.
“PSA supports Victoria starting this process and looks forward to a national approach on this important issue.
“PSA looks forward to working with the Government to ensure the pharmacy workforce is adequately prepared to implement the system and appropriate patient care is provided.”
Read PSA’s Position statement on real-time recording and reporting of drugs of dependence here>>
Media contact: Brad Watts
Executive Director, Communications
0487 922 176
This item is listed in the following categories: • 2017 media releases • Media releases